KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Receivables (2016 - 2025)

Historic Receivables for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $12.1 billion.

  • Merck's Receivables rose 649.33% to $12.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 billion, marking a year-over-year increase of 649.33%. This contributed to the annual value of $10.3 billion for FY2024, which is 68.61% down from last year.
  • As of Q3 2025, Merck's Receivables stood at $12.1 billion, which was up 649.33% from $11.8 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Receivables registered a high of $12.1 billion during Q3 2025, and its lowest value of $8.2 billion during Q1 2021.
  • Over the past 5 years, Merck's median Receivables value was $10.4 billion (recorded in 2023), while the average stood at $10.6 billion.
  • In the last 5 years, Merck's Receivables skyrocketed by 4984.57% in 2021 and then plummeted by 506.77% in 2025.
  • Over the past 5 years, Merck's Receivables (Quarter) stood at $10.2 billion in 2021, then fell by 2.29% to $10.0 billion in 2022, then grew by 3.9% to $10.3 billion in 2023, then decreased by 0.69% to $10.3 billion in 2024, then increased by 17.92% to $12.1 billion in 2025.
  • Its Receivables stands at $12.1 billion for Q3 2025, versus $11.8 billion for Q2 2025 and $10.8 billion for Q1 2025.